Impact of pharmacist consultation at clinical trial inclusion: an effective way to reduce drug-drug interactions with oral targeted therapy.
Fanny LeenhardtMarie AlexandreSeverine GuiuStephane PouderouxMelanie BeaujouinGerald LossaintLaurent PhilibertAlexandre EvrardWilliam JacotPublished in: Cancer chemotherapy and pharmacology (2021)
Clinicaltrials.gov identifier NCT04025541.